institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Zeteo Biomedical Secures Global Patents for Nasal and Ophthalmic Drug Delivery Device Innovations

  • Zeteo Biomedical revealed today that it has been granted new patents in both the U.S. and the EU, recognizing its innovative drug delivery technology.
  • The patents enhance Zeteo's exclusive ZTech platform lineup, which is designed to administer medications and biological treatments through nasal, eye, and under-the-tongue delivery methods.
  • The patented delivery systems include single-use and multi-dose handheld devices that function reliably in various environments, including space-based microgravity.
  • Timothy Sullivan, CEO of Zeteo, noted a growing worldwide interest in user-friendly, small-sized metered-dose products designed for nasal, eye, and sublingual administration that patients can easily use on their own.
  • These innovations could accelerate development of patient-centric drug/device products and open new markets in terrestrial and interstellar healthcare.
Insights by Ground AI
Does this summary seem wrong?

13 Articles

All
Left
4
Center
5
Right
Daily JournalDaily Journal
+10 Reposted by 10 other sources
Center

Zeteo Biomedical Secures Global Patents for Nasal and Ophthalmic Drug Delivery Device Innovations

CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European Union for its advanced drug delivery technologies. The patents, titled…

·Cherokee County, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources are Center
56% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Send2Press Newswire broke the news in United States on Wednesday, June 11, 2025.
Sources are mostly out of (0)